Multicystic dysplastic kidney: Difference between revisions
Line 35: | Line 35: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Multicystic dysplastic kidney history and symptoms|History and Symptoms]] | [[Multicystic dysplastic kidney physical examination|Physical Examination]] | [[Multicystic dysplastic kidney laboratory findings|Laboratory Findings]] | [[Multicystic dysplastic kidney voiding cystourethrography|Voiding Cystourethrography (VCUG)]] | [[Multicystic dysplastic kidney dimercaptosuccinic acid renal scanning|Dimercaptosuccinic Acid (DMSA) Renal Scanning ]] | [[Multicystic dysplastic kidney CT|CT]] | [[Multicystic dysplastic kidney ultrasound|Ultrasound]] | [[Multicystic dysplastic kidney other imaging findings|Other Imaging Findings]] | [[Multicystic dysplastic kidney other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | ==Treatment== |
Revision as of 16:05, 28 September 2012
Multicystic dysplastic kidney | |
Ultrasonography: Multicystic dysplastic kidney Image courtesy of RadsWiki | |
ICD-10 | Q61.4 (EUROCAT Q61.40-Q61.41) |
For patient information, click here
Multicystic dysplastic kidney Microchapters |
Differentiating Multicystic dysplastic kidney from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multicystic dysplastic kidney On the Web |
American Roentgen Ray Society Images of Multicystic dysplastic kidney |
Directions to Hospitals Treating Multicystic dysplastic kidney |
Risk calculators and risk factors for Multicystic dysplastic kidney |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multicystic dysplastic kidney from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Voiding Cystourethrography (VCUG) | Dimercaptosuccinic Acid (DMSA) Renal Scanning | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies